Biosimilars and haemophilia
Haemophilia
.
2018 Jan;24(1):17-19.
doi: 10.1111/hae.13380.
Author
A E Thomas
1
Affiliation
1
Clinical Trials, Biologicals and Vaccines Expert Advisory Group, Commission on Human Medicines, London, UK.
PMID:
29341406
DOI:
10.1111/hae.13380
No abstract available
Publication types
Editorial
MeSH terms
Biosimilar Pharmaceuticals / therapeutic use*
Hemophilia A / drug therapy*
Hemophilia B / drug therapy*
Humans
Substances
Biosimilar Pharmaceuticals